Struggling Avivagen exploring potential sale as part of strategic review

Cows eating
Avivagen is reviewing “strategic alternatives” that could include selling the embattled Ottawa-based life sciences company as it struggles to gain market traction for its natural immune-boosting compound.
Already an Insider? Log in

Get Instant Access to This Article

Become an Ottawa Business Journal Insider and get immediate access to all of our Insider-only content and much more.

Get our email updates

Get up-to-date news about the companies, people and issues that impact businesses in Ottawa and beyond.